222 related articles for article (PubMed ID: 34108014)
1. Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.
Peixoto A; Ferreira D; Azevedo R; Freitas R; Fernandes E; Relvas-Santos M; Gaiteiro C; Soares J; Cotton S; Teixeira B; Paulo P; Lima L; Palmeira C; Martins G; Oliveira MJ; Silva AMN; Santos LL; Ferreira JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):191. PubMed ID: 34108014
[TBL] [Abstract][Full Text] [Related]
2. Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.
Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; Neves M; Neves D; Amaro T; Cruz R; Tavares A; Rangel M; Silva AMN; Santos LL; Ferreira JA
Mol Oncol; 2017 Aug; 11(8):895-912. PubMed ID: 28156048
[TBL] [Abstract][Full Text] [Related]
3. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
[No Abstract] [Full Text] [Related]
4. Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.
Peixoto A; Fernandes E; Gaiteiro C; Lima L; Azevedo R; Soares J; Cotton S; Parreira B; Neves M; Amaro T; Tavares A; Teixeira F; Palmeira C; Rangel M; Silva AM; Reis CA; Santos LL; Oliveira MJ; Ferreira JA
Oncotarget; 2016 Sep; 7(39):63138-63157. PubMed ID: 27542232
[TBL] [Abstract][Full Text] [Related]
5. HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
Liu Q; He L; Li S; Li F; Deng G; Huang X; Yang M; Xiao Y; Chen X; Ouyang Y; Chen J; Wu X; Wang X; Song L; Lin C
J Hematol Oncol; 2021 Jan; 14(1):6. PubMed ID: 33407765
[TBL] [Abstract][Full Text] [Related]
6. Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.
Azevedo R; Soares J; Gaiteiro C; Peixoto A; Lima L; Ferreira D; Relvas-Santos M; Fernandes E; Tavares A; Cotton S; Daniel-da-Silva AL; Santos LL; Vitorino R; Amado F; Ferreira JA
Talanta; 2018 Jul; 184():347-355. PubMed ID: 29674052
[TBL] [Abstract][Full Text] [Related]
7. In silico approaches for unveiling novel glycobiomarkers in cancer.
Azevedo R; Silva AMN; Reis CA; Santos LL; Ferreira JA
J Proteomics; 2018 Jan; 171():95-106. PubMed ID: 28782717
[TBL] [Abstract][Full Text] [Related]
8. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
9. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.
Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; Santos LL; Sackstein R; Videira PA
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2069-2080. PubMed ID: 29777742
[TBL] [Abstract][Full Text] [Related]
10. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
11. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
[TBL] [Abstract][Full Text] [Related]
12. Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells.
Fernandes E; Freitas R; Ferreira D; Soares J; Azevedo R; Gaiteiro C; Peixoto A; Oliveira S; Cotton S; Relvas-Santos M; Afonso LP; Palmeira C; Oliveira MJ; Ferreira R; Silva AMN; Lara Santos L; Ferreira JA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32252346
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.
Smith V; Lee D; Reardon M; Shabbir R; Sahoo S; Hoskin P; Choudhury A; Illidge T; West CML
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240301
[TBL] [Abstract][Full Text] [Related]
14. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
[TBL] [Abstract][Full Text] [Related]
15. The Hitchhiker's guide to glycoproteomics.
Oliveira T; Thaysen-Andersen M; Packer NH; Kolarich D
Biochem Soc Trans; 2021 Aug; 49(4):1643-1662. PubMed ID: 34282822
[TBL] [Abstract][Full Text] [Related]
16. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012.
Leymarie N; Griffin PJ; Jonscher K; Kolarich D; Orlando R; McComb M; Zaia J; Aguilan J; Alley WR; Altmann F; Ball LE; Basumallick L; Bazemore-Walker CR; Behnken H; Blank MA; Brown KJ; Bunz SC; Cairo CW; Cipollo JF; Daneshfar R; Desaire H; Drake RR; Go EP; Goldman R; Gruber C; Halim A; Hathout Y; Hensbergen PJ; Horn DM; Hurum D; Jabs W; Larson G; Ly M; Mann BF; Marx K; Mechref Y; Meyer B; Möginger U; Neusüβ C; Nilsson J; Novotny MV; Nyalwidhe JO; Packer NH; Pompach P; Reiz B; Resemann A; Rohrer JS; Ruthenbeck A; Sanda M; Schulz JM; Schweiger-Hufnagel U; Sihlbom C; Song E; Staples GO; Suckau D; Tang H; Thaysen-Andersen M; Viner RI; An Y; Valmu L; Wada Y; Watson M; Windwarder M; Whittal R; Wuhrer M; Zhu Y; Zou C
Mol Cell Proteomics; 2013 Oct; 12(10):2935-51. PubMed ID: 23764502
[TBL] [Abstract][Full Text] [Related]
18. Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
Azevedo R; Peixoto A; Gaiteiro C; Fernandes E; Neves M; Lima L; Santos LL; Ferreira JA
Oncotarget; 2017 Oct; 8(53):91734-91764. PubMed ID: 29207682
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy.
Gbormittah FO; Lee LY; Taylor K; Hancock WS; Iliopoulos O
J Proteome Res; 2014 Nov; 13(11):4889-900. PubMed ID: 25184692
[TBL] [Abstract][Full Text] [Related]
20. HOMER3 promotes non-small cell lung cancer growth and metastasis primarily through GABPB1-mediated mitochondrial metabolism.
Sun T; Song C; Zhao G; Feng S; Wei J; Zhang L; Liu X; Li Z; Zhang H
Cell Death Dis; 2023 Dec; 14(12):814. PubMed ID: 38081871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
